🇺🇸 FDA
Company

Werewolf

Werewolf Therapeutics

HOWL pharma USA

Quick answer

Werewolf is a pharma company (HOWL) headquartered in WATERTOWN, MA, USA with 2 tracked pipeline programs.

Pipeline (2)

project

WTX-330

Advanced or Metastatic Solid Tumors

Phase 2 · small_molecule · active

2 trials project

WTX-124

Metastatic Solid Tumor

Phase 1 · small_molecule · active

1 trials

Patents (8)

patent

US 12275769

Activatable interleukin 12 polypeptides and methods of use thereof

Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12076371

Activatable cytokine polypeptides and methods of use thereof

Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12036266

Activatable cytokine polypeptides and methods of use thereof

Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11981716

Activatable interleukin-2 polypeptides and methods of use thereof

Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11739132

Separation moieties and methods of use thereof

Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11535658

Activatable interleukin-2 polypeptides and methods of use thereof

Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11453710

Activatable interleukin 12 polypeptides and methods of use thereof

Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11352403

Activatable interleukin-2 polypeptides and methods of use thereof

Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)